A new study from the University of California investigated the association between GLP-1 receptor agonists (GLP-1 medications) and five-year mortality in patients with primary colorectal cancer
3,4 It is known to be antimelanogenic, thereby associated with melanin production
Research across populations from Italy, Arkansas, and China found that only 20-37% are fast metabolizers, with 51-67% intermediate and 12-13% slow metabolizers
doi: 10.3390/ijerph18179245 17 GreggEWBuckleyJAliMKDaviesJFloodDMehtaRet al
The phase 3 REDEFINE 1 trial expanded on these findings dramatically
They work by: Slowing digestion Reducing appetite Helping you feel full longer Stabilizing blood sugar levels Together, these effects can reduce cravings and support more consistent, sustainable weight loss when combined with lifestyle changes